News
Analysts estimate that Merck & Co will report an earnings per share (EPS) of $2.01. Investors in Merck & Co are eagerly ...
Science does not support aluminum as a culprit of autism. Yet RFK Jr. and his associates continue to find ways to support the ...
Merck has had a successful track record of beating estimates, having surpassed EPS expectations 88% of the time and beating ...
Merck & Co., Inc. (NYSE:MRK) is one of the top low volatility healthcare stocks to buy now. Analyst Daina Graybosch of ...
Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, ...
The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will ...
Three critically ill patients treated with procizumab experience a full reversal of cardiogenic shock in 48 hours.
Merck is undervalued with strong growth, profitability, and credit strength despite CDMO challenges, offering compelling ...
Merck & Co., Inc. (NYSE:MRK) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. Merck & Co., Inc. (NYSE:MRK ...
15mon MSN
The healthcare sector, including managed-care firms and drug powerhouses, is vastly underperforming the S&P 500 index. Here ...
The deal, which will focus first on a COPD therapy GSK believes holds “best-in-class” potential, could ultimately involve a ...
Merck & Co., Inc. (NYSE:MRK) ranks among the best magic formula stocks to invest in. On July 10, UBS reiterated its Buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results